Veracyte Inc
Diagnostics & Research
Healthcare
VCYT
78.46 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
27.22
52 week high
46.14
high
33.21
52 week low
20.65
low
27.22
growth
57.20 %
previous Close
28.88
P/E ratio
market cap
3.17 B
div yield
0
usd
Sep 2024
qoq
revenue
116 M
1.25 %
net incoming
15.16 M
164.30 %
eps
0.00 %
171.43 %
eps surprise
533.33 %
net profit margin
13.08 %
8.00 %
operating incoming
12.02 M
155.35 %
net change in cash
38.16 M
42.76 %
cash on hand
274 M
16.18 %
cost of revenue
36.85 M
-4.64 %
top top